Clinical behavior and treatment outcome of primary nasal diffuse large B-cell lymphoma
Cancer, 08/12/2011
Lu NN et al.– The current results indicated that primary nasal diffuse large B–cell lymphoma (DLBCL) appears to have distinct clinical features; its poor outcome and propensity for extranodal failure illustrate the need for innovative therapies.






